ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
David S. Bach
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bach, D. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bach, D. S.
Related Collections
Right arrow Valve disease

Ann Thorac Surg 2005;80:1705
© 2005 The Society of Thoracic Surgeons

Original article: Cardiovascular

Invited commentary

David S. Bach, MD

The University of Michigan, L3119 Women's–0273, 1500 E Medical Center Dr, Ann Arbor, MI48109

(Email: dbach@umich.edu).

The first 20% of the full text of this article appears below.


Dr Bach discloses a financial relationship with Edwards Lifesciences, Medtronic, and St. Jude Medical.

 

The authors [1] are to be commended for their careful study of a large cohort of predominantly elderly patients who underwent aortic valve replacement with a Mitroflow Synergy pericardial prosthesis (Sorin Group . . . [Full Text of this Article]






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2005 by The Society of Thoracic Surgeons.